Showing results (1491-1500 of 5,587) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|October 1, 2019
Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancerMehmet Erdogan, Evrim Erdemoglu, Şehnaz Evrimler, et al.
Nuclear Medicine Communications|October 1, 2019
18F-choline positron emission tomography/computed tomography for the detection of prostate cancer relapse: assessment of maximum standardized uptake value correlation with prostate-specific antigen levelsNatalia Siminiak, Karolina Wojciechowska, Izabela Miechowicz, et al.
Nuclear Medicine Communications|January 22, 2021
Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinomaYang Song, Peng-Yuan Wang, Yang Zheng, et al.
Nuclear Medicine Communications|January 14, 2021
Chronic thromboembolic pulmonary hypertension: evaluation of V/Q SPECT/CT and V/Q Quotient SPECT findings with postoperative results of pulmonary endarterectomySalih Ozguven, Tunc Ones, Emine Bozkurtlar, et al.
Nuclear Medicine Communications|January 13, 2022
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancerLuca Urso, Natale Quartuccio, Matteo Caracciolo, et al.
Nuclear Medicine Communications|December 15, 2021
Safety and tolerability of regadenoson compared with dipyridamole in myocardial perfusion imaging in patients scheduled to undergo medium to high-risk noncardiac surgery: a randomized controlled studyPetros Z Stavrou, Kali Polytarchou, Chariklia Giannopoulou, et al.
Nuclear Medicine Communications|December 15, 2021
Prediction of pathological response using 18F FDG PET/CT derived metabolic parameters in locally advanced breast cancer patientsSalwa Abd El-Gaid, Marwa Nabil AbdelHafez, Ghada Mohamed, et al.
Nuclear Medicine Communications|January 19, 2022
Evaluation of fluorine-18-fluorodeoxyglucose PET/computed tomography and human epithelial growth factor receptor 2 expression in treatment-naive patients with lung adenocarcinomaYuan Li, Xiaodong Wu, Juanjuan Fang, et al.
Nuclear Medicine Communications|January 19, 2022
Optimization of pediatric FDG-PET/CT examinations based on physical indicators using the SiPM-PET/CT systemYoshiki Owaki, Kazuya Minamishima, Kiyotaka Nakajima
Nuclear Medicine Communications|January 19, 2022
Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET/computed tomography in articular manifestation of rheumatoid arthritisShamim Ahmed Shamim, Geetanjali Arora, Naresh Kumar, et al.
Pageof 559